Alumasc Group PLC
23 November 2007
Alumasc Group Plc
23 November 2007
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
The Alumasc Group Plc
2. Reason for the notification (please state Yes/No): ( )
An acquisition or disposal of voting rights: (YES )
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
3. Full name of person(s) subject to the notification obligation (iii):
AXA S.A., 25 Avenue Matignon, , 75008 Paris and its Group of Companies
4. Full name of shareholder(s) (if different from 3.) (iv):
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
20 November 2007
6. Date on which issuer notified:
21 November 2007
7. Threshold(s) that is/are crossed or reached:
19%
8. Notified details:
.................
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the
using the ISIN CODE Triggering transaction (vi)
Number of Number of voting
shares Rights (viii)
0028035 6,864,636 6,864,636
Resulting situation after the triggering transaction (vii)
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using (ix)
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
2,500 2,500 6,713,563 0.01 18.73
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting % of voting
rights rights
6,716,063 18.74%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
Registered holder Number of shares Percentage of issued
share capital
AXA Rosenburg 1,233,879 3.44%
Indirect
AXA Framlington - 750,000 2.09%
Income & Capital
Indirect
AXA Framlington -Equity 3,209,684 8.96%
Income
Indirect
Framlington - Monthly 1,475,000 4.12%
Income
Sun Life Pensions 2,500 0.007
Management Ltd
Direct
AXA Framlington - St 45,000 0.13
James Place Internal
Equity & Income UT
Indirect
Direct - 2,500 0.007
Indirect - 2,713,563 18.73%
Total Total - 6,716,063 18.74%
Proxy Voting:
10. Name of the proxy holder:
.................
11. Number of voting rights proxy holder will cease to hold:
.................
12. Date on which proxy holder will cease to hold voting rights:
.................
13. Additional information:
14. Contact name:
Terry Marsh
15. Contact telephone number:
020 7003 2637
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.